www.sciencedaily.com
Cedars-Sinai researchers have developed TY1, a novel experimental drug designed to enhance DNA repair and tissue regeneration. Inspired by studying natural healing signals from heart cells, they identified powerful molecular messages that promote recovery. This led to the creation of a synthetic RNA molecule, TY1, which bolsters the body’s inherent DNA-repair mechanisms. Early findings suggest TY1 can reduce scarring and potentially improve recovery outcomes following heart attacks and other diseases by facilitating more efficient tissue repair.
